Health Catalyst, Inc.·4

May 1, 4:33 PM ET

Albert Benjamin 4

4 · Health Catalyst, Inc. · Filed May 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Health Catalyst CEO Albert Benjamin Receives PRSUs, Sells 310 Shares

What Happened

  • Albert Benjamin, CEO and director of Health Catalyst (HCAT), was granted 1,124 performance-based restricted stock units (PRSUs) on April 29, 2026. The award is reported at $0.00 per share because it is a contingent PRSU award tied to 2025 performance and board approval.
  • On May 1, 2026, 310 shares were disposed of at $1.34 per share (proceeds ≈ $417). This disposal was to satisfy tax withholding obligations in connection with vested restricted stock units and was a mandatory "sell to cover," not a discretionary sale.

Key Details

  • Transaction dates and prices: Grant (A) on 2026-04-29 — 1,124 PRSUs @ $0.00; Tax-withholding sale (F) on 2026-05-01 — 310 shares @ $1.34 (≈ $417).
  • Shares owned after transaction: Not specified in the excerpt of the filing provided.
  • Footnotes: F1 — PRSUs are contingent rights to one share each based on 2025 performance (board approved 4/29/2026). F2 — The 310-share sale was a mandatory sell-to-cover for tax withholding under the issuer’s equity plans and not a discretionary trade.
  • Filing timeliness: Form 4 was filed 2026-05-01 reporting a 2026-04-29 grant and a 2026-05-01 tax-withholding sale; the filing appears timely based on the transaction dates.

Context

  • PRSUs are performance-contingent awards that convert to shares only if specified performance goals are met; they are not an immediate cash purchase. The small sale was routine tax withholding, which is common and generally not interpreted as an expression of market sentiment by the insider.

Insider Transaction Report

Form 4
Period: 2026-04-29
Albert Benjamin
DirectorCEO
Transactions
  • Award

    Common Stock

    [F1]
    2026-04-29+1,1241,459,102 total
  • Tax Payment

    Common Stock

    [F2]
    2026-05-01$1.34/sh310$4171,458,792 total
Footnotes (2)
  • [F1]Represents an award of 1,124 performance-based restricted units of the Issuer ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025, approved by the Issuer's board of directors on April 29, 2026. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-05-01

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT